We then evaluated the relevance of tumor-derived IL-1 in driving TSLP secretion by CAFs in vivo by using immunodeficient NSG mice orthotopically injected with IL-1 positive human PDAC cells plus CAFs and treated with anakinra, following the scheme depicted in Fig. 2a. The gene discussed is IL1A; the disease is neoplasm.